Dr. Peter McCullough

And so I'm guessing some of those immune suppressives that she was taking for the scleroderma may be the responsible. And she was older, may be the responsible party. That is so sad. Did anybody attempt to get monoclonal antibodies in her? Because my God, that works so well.

And so I'm guessing some of those immune suppressives that she was taking for the scleroderma may be the responsible. And she was older, may be the responsible party. That is so sad. Did anybody attempt to get monoclonal antibodies in her? Because my God, that works so well.

They work so well, you know, they're currently not available. She was in a rural Texas location. They did the best they could, but you know, I went through the whole scenario with a surviving husband and by the time she came in, fever and then hypotension, hypothermia, before you know it, they were doing CPR and there was no chance. It was that fulminant.

They work so well, you know, they're currently not available. She was in a rural Texas location. They did the best they could, but you know, I went through the whole scenario with a surviving husband and by the time she came in, fever and then hypotension, hypothermia, before you know it, they were doing CPR and there was no chance. It was that fulminant.

So I want to remind people that there's estimated about 3% of Americans have still not yet had COVID. Those are the people who still could have severe disease.

So I want to remind people that there's estimated about 3% of Americans have still not yet had COVID. Those are the people who still could have severe disease.

During the pandemic, or late in the hours of the pandemic, Toxeluzumab had some utility in patients like this because a lot of this overwhelming immune response is this so-called cytokine storm. But who knows? You know what I mean? Sometimes the body just can't withstand this, particularly if you're monkeying with the immune system with very powerful medication.

During the pandemic, or late in the hours of the pandemic, Toxeluzumab had some utility in patients like this because a lot of this overwhelming immune response is this so-called cytokine storm. But who knows? You know what I mean? Sometimes the body just can't withstand this, particularly if you're monkeying with the immune system with very powerful medication.

It's true. You know, I had examined her multiple times. She was so frail and recall in a scleroderma system of sclerosis, the skin on the body gets very tight and there's a form of restrictive lung disease. She had the effects on her hands. And in that scenario, even a bacterial pneumonia, like a pneumococcal or haemophilus influenza pneumonia could be fatal as well.

It's true. You know, I had examined her multiple times. She was so frail and recall in a scleroderma system of sclerosis, the skin on the body gets very tight and there's a form of restrictive lung disease. She had the effects on her hands. And in that scenario, even a bacterial pneumonia, like a pneumococcal or haemophilus influenza pneumonia could be fatal as well.

So remember the theme here, Dr. Drew, is that in the setting of COVID, it was the frail and those who are particularly at risk for death of other pneumonias that indeed died of COVID.

So remember the theme here, Dr. Drew, is that in the setting of COVID, it was the frail and those who are particularly at risk for death of other pneumonias that indeed died of COVID.

Right, and the scleroderma patients get pulmonary hypertension, and God knows what that did to the, maybe she had diffused clotting or something. Who the hell knows? I mean, it's a whole thing. Well, okay, so no one ever said, at least not you or me, ever said COVID wasn't a severe illness.

Right, and the scleroderma patients get pulmonary hypertension, and God knows what that did to the, maybe she had diffused clotting or something. Who the hell knows? I mean, it's a whole thing. Well, okay, so no one ever said, at least not you or me, ever said COVID wasn't a severe illness.

We wondered how severe for people who were young, which generally without risk factors, it tends to be quite mild and still is, even though, and particularly as we've gone through the incarnations of the new variants. I personally am gravely concerned about the continued sort of man, the various variants.

We wondered how severe for people who were young, which generally without risk factors, it tends to be quite mild and still is, even though, and particularly as we've gone through the incarnations of the new variants. I personally am gravely concerned about the continued sort of man, the various variants.

sporadic mandates that are out there for young people to get them to go to school and to go to college and whatnot. And when there is only risk, even though yes, this is a severe illness and it hits an elderly patient with scleroderma and can kill them, it doesn't mean a 22 year old is at risk of that.

sporadic mandates that are out there for young people to get them to go to school and to go to college and whatnot. And when there is only risk, even though yes, this is a severe illness and it hits an elderly patient with scleroderma and can kill them, it doesn't mean a 22 year old is at risk of that.

And giving them a product that we know in that age group in particular causes myocarditis, pericarditis. I don't understand why we're still pushing that. And it sort of also brings up the other point. I'll let you talk at length about both these issues. Why we still demand we use the vaccines that produce the spike protein. Why we aren't using whole viral alternatives.

And giving them a product that we know in that age group in particular causes myocarditis, pericarditis. I don't understand why we're still pushing that. And it sort of also brings up the other point. I'll let you talk at length about both these issues. Why we still demand we use the vaccines that produce the spike protein. Why we aren't using whole viral alternatives.